130 related articles for article (PubMed ID: 6801943)
1. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topic N; Kramer B; Massie B
Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
[TBL] [Abstract][Full Text] [Related]
3. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
Awan NA; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
[TBL] [Abstract][Full Text] [Related]
4. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Halperin JL; Melidossian CD; McCabe CH; Schick EC; Ryan TJ
Am Heart J; 1982 Nov; 104(5 Pt 2):1147-54. PubMed ID: 6291360
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
6. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure.
Massie BM; Kramer BL; Topic N
Am Heart J; 1982 Nov; 104(5 Pt 2):1197-203. PubMed ID: 6291366
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
Hermanovich J; Awan NA; Lui H; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551
[TBL] [Abstract][Full Text] [Related]
8. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
Awan NA; Needham KE; Lui H; Rutledge J; Amsterdam EA; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1224-8. PubMed ID: 6753553
[TBL] [Abstract][Full Text] [Related]
9. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
[TBL] [Abstract][Full Text] [Related]
10. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
[TBL] [Abstract][Full Text] [Related]
13. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
Cody RJ; Covit A; Schaer G; Williams G
Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
[TBL] [Abstract][Full Text] [Related]
14. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
16. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
17. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
Chatterjee K; Rouleau JL; Parmley WW
Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359
[TBL] [Abstract][Full Text] [Related]
18. The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.
Powers ER; Bannerman KS; Stone J; Reison DS; Escala EL; Kalischer A; Weiss MB; Sciacca RR; Cannon PJ
Am Heart J; 1982 Nov; 104(5 Pt 2):1203-10. PubMed ID: 6753550
[TBL] [Abstract][Full Text] [Related]
19. Converting-enzyme inhibitor therapy for chronic heart failure.
Massie BM; Kramer BL; Topic N
Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
[TBL] [Abstract][Full Text] [Related]
20. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
